Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 24.13%8.01B | 22.07%2.12B | 27.06%2.13B | 24.98%1.96B | 22.29%1.8B | -55.17%6.46B | -56.74%1.74B | -57.23%1.68B | -55.00%1.57B | -50.53%1.47B |
Cost of revenue | 42.72%1.87B | 38.80%501.4M | 44.11%487.13M | 45.94%462.12M | 42.48%422.91M | -87.68%1.31B | -87.66%361.23M | -88.53%338.02M | -87.87%316.66M | -86.36%296.81M |
Gross profit | 19.38%6.14B | 17.67%1.62B | 22.76%1.65B | 19.69%1.5B | 17.18%1.37B | 37.42%5.14B | 26.38%1.38B | 36.88%1.34B | 42.43%1.25B | 47.69%1.17B |
Operating expense | 71.31%4.6B | 572.50%1.32B | 31.80%1.29B | -27.57%727.51M | 29.04%1.27B | -14.86%2.69B | -128.46%-278.68M | 35.55%979.06M | 35.79%1B | 37.57%980.49M |
Selling and administrative expenses | 31.11%5.25B | 30.03%1.42B | 27.90%1.29B | 27.63%1.28B | 39.81%1.27B | 37.71%4.01B | 46.82%1.09B | 39.54%1.01B | 37.04%1B | 27.08%905.58M |
-General and administrative expense | 31.11%5.25B | 30.03%1.42B | 27.90%1.29B | 27.63%1.28B | 39.81%1.27B | 37.71%4.01B | 46.82%1.09B | 39.54%1.01B | 37.04%1B | 27.08%905.58M |
Other operating expenses | -93.56%23.32M | -93.83%17.61M | 113.90%2.08M | 294.83%1.15M | -96.69%2.49M | 46.37%361.91M | 19.86%285.56M | 38.12%971K | -96.36%290K | 20,699.45%75.09M |
Total other operating income | -59.83%676.22M | -92.96%116.43M | -96.25%1.13M | 377,691.16%555.35M | 1,782.95%3.31M | 58,591.14%1.68B | 258,973.67%1.65B | 3,345.99%30.05M | -86.88%147K | -25.74%176K |
Operating profit | -37.37%1.54B | -81.74%302.1M | -1.67%356.01M | 209.88%773.39M | -43.74%107.49M | 317.74%2.46B | 1,411.05%1.65B | 40.61%362.06M | 77.36%249.57M | 137.32%191.06M |
Net non-operating interest income (expenses) | -47.00%-261.81M | 52.08%-104.09M | 164.82%32.49M | -8,485.17%-88M | -466.58%-102.21M | -238.00%-178.11M | -1,355.59%-217.23M | -64.85%12.27M | -101.65%-1.03M | 88.95%27.88M |
Non-operating interest income | 56.17%31.17M | 110.46%6.28M | 25.54%32.49M | -85.05%2.38M | -51.96%18.34M | -87.14%19.96M | -380.23%-60.03M | -35.11%25.88M | -77.77%15.94M | 71.34%38.17M |
Non-operating interest expense | 47.92%292.99M | -29.79%110.37M | ---- | 432.88%90.38M | 1,071.51%120.55M | 655.98%198.07M | 3,716.58%157.21M | 173.57%13.61M | 77.01%16.96M | 36.80%10.29M |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | ||||||||||
Other non-operating income (expenses) | ||||||||||
Income before tax | -43.96%1.28B | -86.22%198.01M | 3.79%388.5M | 175.76%685.39M | -97.59%5.28M | 217.74%2.28B | 1,033.53%1.44B | 28.02%374.32M | 22.55%248.55M | 129.83%218.94M |
Income tax | 43.87%242.14M | 171.41%30.45M | 139.26%156.9M | -48.86%51.93M | -93.49%2.85M | -5.31%168.31M | -185.85%-42.63M | 3.85%65.58M | 193.22%101.56M | 44.54%43.8M |
Net income | -50.96%1.04B | -88.68%167.57M | -24.99%231.59M | 330.96%633.45M | -98.61%2.43M | 291.22%2.11B | 1,818.60%1.48B | 34.68%308.75M | -12.60%146.99M | 169.62%175.13M |
Net income continuous operations | -50.96%1.04B | -88.68%167.57M | -24.99%231.59M | 330.96%633.45M | -98.61%2.43M | 291.22%2.11B | 1,818.60%1.48B | 34.68%308.75M | -12.60%146.99M | 169.62%175.13M |
Noncontrolling interests | 178.37%3.15M | -376.62%-2.9M | 262.68%2.7M | 167.06%1.99M | 147.61%1.35M | -110.32%-4.01M | -97.20%1.05M | 8.13%745K | -237.19%-2.97M | -93.33%-2.84M |
Net income attributable to the company | -51.20%1.03B | -88.47%170.46M | -25.68%228.89M | 321.11%631.46M | -99.39%1.08M | 322.40%2.11B | 3,630.54%1.48B | 34.76%308M | -9.68%149.95M | 167.93%177.98M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -51.20%1.03B | -88.47%170.46M | -25.68%228.89M | 321.11%631.46M | -99.39%1.08M | 322.40%2.11B | 3,630.54%1.48B | 34.76%308M | -9.68%149.95M | 167.93%177.98M |
Gross dividend payment | ||||||||||
Basic earnings per share | -51.21%58.31 | -88.49%9.62 | -25.77%12.93 | 320.87%35.69 | -99.40%0.06 | 329.00%119.52 | 3,614.67%83.58 | 36.73%17.42 | -8.03%8.48 | 173.10%10.05 |
Diluted earnings per share | -51.20%58.29 | -88.48%9.62 | -25.79%12.92 | 321.25%35.68 | -99.40%0.06 | 330.76%119.45 | 3,629.02%83.53 | 37.30%17.41 | -7.73%8.47 | 174.32%10.04 |
Dividend per share | ||||||||||
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |